Emerging BioCommunications

Emerging BioCommunications helps startup and clinical-stage biopharmas tell their story to the audiences that matter.

Emerging BioCommunications, part of Slowey McManus Communications, is a boutique agency that specializes in helping startup and clinical-stage biopharma companies tell their stories to the audiences that matter: investors, scientists, big pharma partners, patient groups and the public. Whether you are preparing to emerge from stealth mode or are preparing to release pivotal clinical trial results, our team of communications pros ensures that your news gets out and reaches the people that matter.

We help with a company's entire communications platform: visual communications, logo, pitch deck, web site, social media strategy, video, and news releases. We help new companies define what they do and why it matters, and then we get that story in front of the right audience.

We build integrated communications campaigns that include news, thought leadership, social media and visual media into a combined effort that builds a company's brand and supports business development.

Our background as news reporters and editors means we can make your story compelling, and explain why the work you do matters.